Co-Diagnostics, Inc. (CODX)
CODXNASDAQ-CMMedical/Dental Instruments
$0.4480
+0.1912 (+74.45%) today
Closed, Nov 9, 4:00 PM ET
- Market cap
- $2.81m
- P/E
- –
- EPS, last 4 quarters
- –
- Dividend yield
- –
- Day range
- –
- 52-week range
- $0.2450 to $13.54
- Average volume
- 361.6k
- Previous close
- $0.2568
Earnings
Next report Nov 12, 2026
Financials
| Quarter | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | $145.0k | $264.0k | $146.0k | $166.0k |
| Gross profit | $119.0k | $122.0k | -$48.0k | $121.0k |
| Operating income | -$7.01m | -$26.54m | -$9.21m | -$6.20m |
| Net income | -$5.89m | -$25.75m | -$9.14m | -$6.28m |
Last four quarters: revenue $721.0k, margin -6526.6%, free cash flow -$27.47m
News
8 latest- Co-Diagnostics Expands Vector Smart With First Tribal Laboratory Installation RTTNews · Oct 8, 2026
- Co-Diagnostics, ReadyGo Advance Blood-Based Ebola Testing At The Point Of Need; Stock Down RTTNews · Sep 16, 2026
- Co-Dx (CODX) Q2 2026 Earnings Call TranscriptThe Motley Fool · Aug 20, 2026
- Co-Diagnostics And CoSara Advance Development Of Ebola PCR Test And Point-of-Care Platform; Stock Up RTTNews · Jun 2, 2026
- Top Biotech Gainers: SPRC Deal Gets Nod, CODX Rallies, OTLK, AKTX, FTRE Drawing Investor Interest RTTNews · May 29, 2026
- Is Co-Diagnostics National Security’s Next Diagnostic Pick?MarketBeat · May 28, 2026
- Pre Market Movers: WGRX, CODX, AIM Set The Pace RTTNews · May 28, 2026
- Co-Diagnostics (CODX) Q4 2025 Earnings TranscriptThe Motley Fool · May 27, 2026
The company
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform (subject to regulatory review and not currently for sale) and to identify genetic markers for use in applications other than infectious disease.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Exchange
- NASDAQ-CM
- Region
- North America
- Website
- codiagnostics.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.